# Activation of SNr GABA neurons drives liver-brain-eye axis dysfunction in hepatic encephalopathy

**Authors:** Kenan Li, Zhenhua Wang, Shaoheng Li, Feifei Wu, Yunhu Bai, Shujiao Li, Changlei Zhu, Ziwei Ni, Shuai Zhang, Yousheng Wu, Fei Tian, Nannan Liu, Tao Chen, Cailian Ruan, Zuoming Zhang, Yanling Yang, Yayun Wang

PMC · DOI: 10.1016/j.isci.2026.114720 · 2026-01-16

## TL;DR

This study reveals that overactive brain neurons link liver disease to vision problems, offering a new understanding of how liver failure affects the brain and eyes.

## Contribution

The study identifies a specific brain pathway responsible for liver-brain-eye dysfunction in hepatic encephalopathy.

## Key findings

- Aberrant activation of mSNrGAD2 neurons was observed in acute hepatic encephalopathy.
- Chemogenetic inhibition of the mSNrGAD2-SC pathway restored retinal function and reduced GABA release.
- Chronic hepatic encephalopathy caused retinal layer thinning, unlike acute cases.

## Abstract

Hepatic encephalopathy (HE) is frequently accompanied by visual dysfunction, yet the mechanisms underlying the liver-brain-eye axis remain unclear. We established mouse models of acute hepatic encephalopathy (AHE) using thioacetamide and chronic hepatic encephalopathy (CHE) using bile duct ligation, confirming hyperammonemia and visual impairment by electroretinogram (ERG) and visual evoked potentials (VEPs). Retinal analyses revealed preserved structure in AHE, whereas CHE induced significant thinning of the ganglion cell layer (GCL), inner nuclear layer (INL), and outer plexiform layer (OPL). Viral anterograde tracing identified aberrant activation of medial substantia nigra pars reticulata glutamate decarboxylase 2-positive (mSNrGAD2) projections to the superior colliculus (SC) under AHE conditions. Chemogenetic inhibition of this pathway restored retinal function, normalized visual signal transmission, and reduced retinal γ-aminobutyric acid (GABA) release. These findings identify SNr-SC signaling as a key neural mechanism driving liver-brain-eye axis dysfunction in HE.

•Viral anterograde tracing with TRAP and GAD2-Cre mice showed SNr activation in AHE•Chemogenetic inhibition of the mSNrGAD2-SC pathway alleviated visual dysfunction•Aberrant mSNrGAD2-SC activation underlies the liver-brain-eye axis in HE

Viral anterograde tracing with TRAP and GAD2-Cre mice showed SNr activation in AHE

Chemogenetic inhibition of the mSNrGAD2-SC pathway alleviated visual dysfunction

Aberrant mSNrGAD2-SC activation underlies the liver-brain-eye axis in HE

Molecular physiology; Molecular neuroscience; Neuroanatomy

## Linked entities

- **Genes:** GAD2 (glutamate decarboxylase 2) [NCBI Gene 2572], cre (cyclization recombinase) [NCBI Gene 2777477]
- **Proteins:** GAD2 (glutamate decarboxylase 2), GABA-B-R1 (metabotropic GABA-B receptor subtype 1)
- **Chemicals:** thioacetamide (PubChem CID 2723949)
- **Diseases:** hepatic encephalopathy (MONDO:0001711)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Gad2 (glutamic acid decarboxylase 2) [NCBI Gene 14417] {aka 6330404F12Rik, GAD(65), GAD65, Gad-2}
- **Diseases:** hyperammonemia (MESH:D022124), CHE (MESH:D001925), HE (MESH:D006501), visual dysfunction (MESH:D014786), AHE (MESH:D000071072)
- **Chemicals:** thioacetamide (MESH:D013853), GABA (MESH:D005680)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12907090/full.md

---
Source: https://tomesphere.com/paper/PMC12907090